GlassScriptPhysician profile
Elliott Schwartz
NPI 1376186833
$4,452.31
in general payments reported to CMS, 2019-2025
16 companies · $915 in 2025
The $915 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $248 · 2022: $1,082 · 2023: $1,038 · 2024: $1,169 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,122.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $984.76 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $704.37 | 2022-2025 | Qelbree, Qelbree |
| Neos Therapeutics, LP | $493.27 | 2021-2025 | Cotempla Xr-Odt, Adzenys Xr-Odt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $425.98 | 2023-2025 | Caplyta |
| Ironshore Pharmaceuticals INC. | $380.20 | 2023-2024 | Jornay Pm |
| Tris Pharma INC | $295.26 | 2021-2025 | Onyda Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $178.02 | 2021-2025 | Trintellix |
| Tempus Ai, INC | $173.71 | 2024-2025 | Tempus Pixel, Tempus Pixel |
| Collegium Pharmaceutical, INC. | $152.82 | 2025 | Jornay Pm |
| Sunovion Pharmaceuticals INC. | $148.17 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $136.66 | 2022-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Lundbeck LLC | $125.90 | 2021-2024 | Rexulti |
| Owp Pharmaceuticals, INC. | $96.95 | 2021-2025 | Subvenite, Lamotrigine |
| Alkermes, INC. | $79.33 | 2025 | Aristada, Lybalvi |
| Noven Therapeutics, LLC | $58.87 | 2024-2025 | Xelstrym |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $18.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliott Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.